Advisory Services Network’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3303 |
|
|
2020
Q4 | – | Sell |
-8
| Closed | – | – | 3830 |
|
|
2020
Q3 | $0 | Buy |
+8
| New | – | ﹤0.01% | 3678 |
|
|
2019
Q4 | – | Sell |
-100
| Closed | -$6K | – | 3293 |
|
|
2019
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 2373 |
|
|
2019
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 2371 |
|
|
2019
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 2130 |
|
|
2018
Q4 | $4K | Sell |
100
-50
| -33% | -$2K | ﹤0.01% | 2160 |
|
|
2018
Q3 | $10K | Sell |
150
-100
| -40% | -$6.67K | ﹤0.01% | 1822 |
|
|
2018
Q2 | $20K | Sell |
250
-1,100
| -81% | -$88K | ﹤0.01% | 1552 |
|
|
2018
Q1 | $71K | Sell |
1,350
-800
| -37% | -$42.1K | 0.01% | 1178 |
|
|
2017
Q4 | $115K | Sell |
2,150
-11,825
| -85% | -$633K | 0.01% | 944 |
|
|
2017
Q3 | $833K | Buy |
13,975
+1,750
| +14% | +$104K | 0.1% | 271 |
|
|
2017
Q2 | $964K | Buy |
12,225
+4,225
| +53% | +$333K | 0.13% | 228 |
|
|
2017
Q1 | $664K | Buy |
+8,000
| New | +$664K | 0.1% | 280 |
|